Microarray analysis of microRNA deregulation and angiogenesis-related proteins in endometriosis

R Q Yang1, H Teng1, X H Xu1

  • 1Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun, Jilin Province, China.

Insights

Aberrant microRNA (miRNA) expression in endometriosis influences angiogenesis. Specific miRNA level changes correlate with altered vascular endothelial growth factor A (VEGFA), epidermal growth factor receptor 2 (EGFR2), phosphatase and tensin homolog (PTEN), and C-X-C chemokine receptor type 4 (CXCR4) levels, impacting disease development.

Area of Science:

  • Reproductive Biology
  • Molecular Biology
  • Oncology

Background:

  • Endometriosis is characterized by aberrant angiogenesis.
  • MicroRNA (miRNA) dysregulation is implicated in various diseases, including endometriosis.
  • Understanding miRNA's role in endometriosis pathogenesis is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the aberrant microRNA (miRNA) expression profile in endometriosis.
  • To correlate miRNA expression with key angiogenic and fibrinolytic factors.
  • To elucidate the role of miRNA in the pathogenesis of endometriosis.

Main Methods:

  • MicroRNA expression was quantified using microRNA arrays and reverse-transcription quantitative polymerase chain reaction.
  • Levels of vascular endothelial growth factor A (VEGFA), epidermal growth factor receptor 2 (EGFR2), phosphatase and tensin homolog (PTEN), and C-X-C chemokine receptor type 4 (CXCR4) were measured using enzyme-linked immunosorbent assay.
  • Comparative analysis was performed between endometrial tissue and endometriotic lesions from the same patients.

Main Results:

  • Endometrial tissue exhibited significantly lower levels of miR-200b, miR-15a-5p, miR-19b-1-5p, miR-146a-5p, and miR-200c, and higher levels of miR-16-5p, miR-106b-5p, and miR-145-5p compared to endometriotic lesions.
  • Vascular endothelial growth factor A (VEGFA) was significantly upregulated in endometriotic tissues, while epidermal growth factor receptor 2 (EGFR2), phosphatase and tensin homolog (PTEN), and C-X-C chemokine receptor type 4 (CXCR4) were markedly downregulated.
  • These miRNA expression differences potentially modulate the expression of VEGFA, EGFR2, PTEN, and CXCR4.

Conclusions:

  • Aberrant miRNA expression profiles are characteristic of endometriosis.
  • MicroRNA dysregulation plays a significant role in the pathogenesis of endometriosis by affecting angiogenic and fibrinolytic factors.
  • Altered angiogenic activity in the eutopic endometrium may promote endometrial cell implantation at ectopic sites.